用户，您好！欢迎您进入重大新药创制—内分泌代谢平台！
请
登录
|
注册
NSTL重点领域信息门户
帮助中心
RSS
重点领域信息门户
重大新药创制—内分泌代谢
首页
资源分析
重点信息源
用户空间
高级检索
期刊浏览
您当前的位置：
首页
>
资源分析
来源机构
糖尿病护理(1,314)
DIABETOLOGIA?(811)
糖尿病(542)
t糖尿病(496)
糖尿病肥胖和代谢(412)
临床内分泌学与代谢杂志(275)
细胞代谢(121)
肥胖综述(85)
抗氧化剂和氧化还原信号(84)
当前脂质研究观点(65)
自由基生物与医学(60)
内分泌和代谢趋势(54)
骨和矿物质研究杂志(47)
心理神经内分泌学(34)
柳叶刀-糖尿病和内分泌(20)
自然内分泌学综述(20)
松果体研究杂志(16)
神经内分泌学前沿(14)
内分泌综述(9)
国际肥胖期刊和相关代谢紊乱杂志(2)
国家或组织
美国(1,702)
韩国(1,379)
德国(811)
英国(589)
机构类别
期刊(4,447)
国际重要组织(34)
资源性质
科技论文(4,461)
重要新闻(20)
监测目标对象
BMI(6)
抽取对象
Diabetes(170)
diabetes(163)
American Diabetes Association(156)
type 2 diabetes(146)
first(122)
the American Diabetes Association(112)
Diabetes Care(106)
type 1 diabetes(97)
glucose(94)
insulin resistance(92)
Article Information(79)
BMI(79)
obesity(79)
al(78)
CrossRef(75)
OpenUrl Abstract(74)
PubMed(73)
OpenUrl(70)
Duality of Interest(69)
cardiovascular(69)
obese(69)
HbA1c(66)
cardiovascular disease(64)
CI(63)
Info & Metrics(63)
al ..(63)
diabetic(62)
Download(61)
?(59)
secretion(56)
PDF(55)
K (54)
L (54)
hyperglycemia(53)
D (51)
liver(51)
CA(50)
tissue(49)
Insulin(47)
Next Back(46)
Glucose(46)
hepatic(46)
Science ?(45)
hypoglycemia(45)
USA(44)
JM(43)
Fig(41)
second(41)
First(39)
Next (38)
blood(38)
hypertension(38)
skeletal muscle(37)
Acknowledgments(36)
Contributions(36)
DOI(36)
N Engl J Med(36)
pregnancy(36)
β-cell(36)
Fig(35)
OpenUrl CrossRef(35)
U.S.(35)
genetic(35)
glucose tolerance(35)
fat(34)
islet(34)
Metab(33)
diabetes mellitus(33)
muscle(33)
JM (32)
Type 2 Diabetes(32)
HDL(31)
Lancet Diabetes Endocrinol(31)
MA(31)
View(31)
AL (30)
II(30)
ME(30)
National Institutes of Health(30)
RR(30)
metformin(30)
vascular(30)
Jun(29)
Novo Nordisk(29)
Physiology(29)
T2D(29)
Type 1 Diabetes(29)
renal(29)
Second(28)
overweight(28)
weight loss(28)
C-peptide(27)
Chen(27)
UK(27)
adipocytes(27)
dyslipidemia(27)
G (26)
METHODS(26)
m2(26)
weight gain(26)
Digestive(25)
MD(25)
MJ (25)
beta cell(25)
type 1 diabetes mellitus(25)
ESM Fig(24)
H (24)
Nat Rev(24)
OpenUrl FREE(24)
RNA(24)
hyperglycaemia(24)
infarction(24)
ANOVA(23)
J Clin Invest(23)
RA(23)
RA (23)
Table 1(23)
prediabetes(23)
’s(23)
American(22)
Australia(22)
CVD(22)
Germany(22)
JA(22)
JE (22)
RS(22)
Sci(22)
Student(22)
U.K.(22)
apoptosis(22)
glucagon(22)
glucose intolerance(22)
pancreas(22)
type 2 diabetes mellitus(22)
±(22)
BP(21)
DR(21)
EJ(21)
JL(21)
KM (21)
MO(21)
NJ(21)
Obesity(21)
SJ(21)
X (21)
cholesterol(21)
third(21)
ACE(20)
Clin Endocrinol(20)
ESM(20)
European(20)
JC(20)
JS(20)
Plasma(20)
Pregnancy(20)
San Diego(20)
Sanofi(20)
T1D(20)
brain(20)
CJ (19)
JAMA(19)
JR (19)
NIH(19)
PLoS One(19)
RJ (19)
SJ (19)
endocrine(19)
impaired glucose tolerance(19)
stroke(19)
Am J Physiol(18)
BMJ(18)
Clinical(18)
ELISA(18)
JDRF(18)
JP (18)
Japan(18)
Jul(18)
LA(18)
Lee(18)
NC(18)
PA(18)
Research Design(18)
Type 1 diabetes(18)
coronary artery disease(18)
gestational diabetes mellitus(18)
gut(18)
ketoacidosis(18)
kidney disease(18)
microvascular(18)
receptor(18)
retinopathy(18)
China(17)
ESM Table 1(17)
ESM Table 2(17)
Eli Lilly(17)
F (17)
IN(17)
OGTT(17)
PA (17)
RJ(17)
RM (17)
SD(17)
SK (17)
SM (17)
Sweden(17)
US(17)
adipocyte(17)
diabetes care(17)
diabetic retinopathy(17)
hepatocytes(17)
insulin therapy(17)
leptin(17)
pancreatic islets(17)
AR(16)
Abbott(16)
CGM(16)
Cambridge(16)
DS(16)
Diabetes Care 2014(16)
Diabetologia(16)
ESM Table(16)
GDM(16)
Kim(16)
MJ(16)
OpenUrl FREE (16)
SAS(16)
WA(16)
adipose(16)
atherosclerosis(16)
blood pressure(16)
dapagliflozin(16)
hypoglycaemia(16)
kidney(16)
the National Institutes of Health(16)
total cholesterol(16)
1C(15)
AJ(15)
Anderson(15)
AstraZeneca(15)
Biol Chem(15)
Boehringer Ingelheim(15)
Canada(15)
Clin(15)
DCCT(15)
DK(15)
Davis(15)
Denmark(15)
EDIC(15)
HOMA-IR(15)
Hypertension(15)
JB (15)
JF(15)
JS (15)
Jr (15)
LM (15)
Lachin(15)
MM(15)
Methods.(15)
NASH(15)
Nat Med(15)
OpenUrl View Abstract(15)
Roche(15)
S (15)
SR(15)
TX(15)
Third(15)
View Abstract(15)
absorption(15)
albumin(15)
beta cells(15)
disease(15)
heart failure(15)
infection(15)
insulin-resistant(15)
subcutaneous(15)
the National Institute of Diabetes(15)
white adipose tissue(15)
AH (14)
AUC(14)
Dapagliflozin(14)
GLP-1(14)
KB(14)
Korea(14)
LM(14)
Mol(14)
NY(14)
SA(14)
SE(14)
Summary(14)
Supplementary Fig(14)
Table 2(14)
cardiac(14)
chronic kidney disease(14)
macrophage(14)
secondary(14)
the Declaration of Helsinki(14)
the United States(14)
?±(13)
AA(13)
ADA(13)
AJ (13)
California(13)
DA (13)
Diabetes Mellitus(13)
Diet(13)
France(13)
HA(13)
HA (13)
IBM(13)
J (13)
JW(13)
MI(13)
Merck(13)
N (13)
Nathan(13)
OR(13)
PJ (13)
Pfizer(13)
SAS Institute(13)
SC (13)
Supplementary Data(13)
United States(13)
autoimmune(13)
autoimmunity(13)
brown adipose tissue(13)
coronary heart disease(13)
depression(13)
endothelial(13)
interplay(13)
mice(13)
nonalcoholic steatohepatitis(13)
retinal(13)
type 2 diabetic(13)
β-cells(13)
AP(12)
Akt(12)
American Heart Association(12)
BM(12)
Briefly(12)
Complications(12)
Congress(12)
Diabet Med(12)
Diabetes Control(12)
Europe(12)
Fasting(12)
GAD(12)
IR(12)
Insulin resistance(12)
J Med(12)
JH (12)
KL(12)
L.(12)
LA (12)
LS (12)
London(12)
ME (12)
ML (12)
Mathieu(12)
Merck Sharp & Dohme(12)
ND(12)
Nat Commun(12)
OpenUrl Abstract / FREE(12)
PM (12)
Physiol(12)
SGLT(12)
T cells(12)
TA (12)
Type 2 diabetes(12)
Wu(12)
Xu(12)
Youth(12)
Zhou(12)
capillary(12)
fibrosis(12)
hepatic steatosis(12)
http://www.diabetesjournals.org/content/license.View Abstract(12)
macrophages(12)
murine(12)
plasma(12)
the Diabetes Control and Complications Trial (DCCT(12)
2(11)
A1C(11)
AA (11)
AD(11)
AMPK(11)
Amgen(11)
Atherosclerosis(11)
Bethesda(11)
C57BL/6(11)
C57BL/6J(11)
CA (11)
CV(11)
Cardiovascular(11)
Clin Pract(11)
ClinicalTrials.gov(11)
DEPICT-1(11)
DG(11)
ES(11)
EW(11)
GJ(11)
GWAS(11)
HLA(11)
LS(11)
Liver(11)
NA(11)
Novartis(11)
RC(11)
SEM(11)
SS(11)
Sigma-Aldrich(11)
Swedish(11)
U (11)
VA(11)
Web of Science(11)
cancer(11)
cell death(11)
fibroblast(11)
heart(11)
hyperlipidemia(11)
immune cell(11)
inflammation(11)
insulin-dependent diabetes mellitus(11)
mouse(11)
the T1D Exchange(11)
χ2(11)
%(10)
3E(10)
6 years(10)
Analysis(10)
Austria(10)
Blood Institute(10)
Boston(10)
CC (10)
CM (10)
Cary(10)
Clin Nutr(10)
College Station(10)
Comparison(10)
Cox(10)
DW (10)
F(10)
FL(10)
GA(10)
GraphPad Prism(10)
Harry B. Helmsley(10)
HbA(10)
III(10)
India(10)
JC (10)
JD (10)
JJ (10)
JK(10)
Janssen(10)
Johnson(10)
KD(10)
MD (10)
MG (10)
Medtronic(10)
NAFLD(10)
Nine(10)
Obese(10)
Orlando(10)
PD(10)
Pearson(10)
R01(10)
RL(10)
RP (10)
Roche Diagnostics(10)
SD (10)
Stata(10)
T2DM(10)
TR(10)
Time(10)
University of Washington(10)
al.(10)
apolipoprotein(10)
apoptotic(10)
endothelial cells(10)
hyperglycemic(10)
kidneys(10)
metabolic disorders(10)
paraformaldehyde(10)
two(10)
FREE (9)
Standards of Medical Care(9)
11(9)
ANCOVA(9)
American Association(9)
Asian(9)
Bethesda, MD(9)
CA, USA(9)
CJ(9)
CP(9)
Canagliflozin(9)
Cary, NC(9)
Danish(9)
Diagnosis(9)
Fourth(9)
GM(9)
Glucagon(9)
监测主题
blood glucose(61)
blood sugar(2)
抽取主题
increased risk(105)
insulin resistance(72)
body weight(59)
glucose tolerance(55)
glycemic control(53)
weight loss(51)
insulin sensitivity(50)
high-fat diet(49)
high risk(48)
cardiovascular disease(47)
adipose tissue(46)
skeletal muscle(46)
glucose metabolism(41)
glycaemic control(38)
glucose intolerance(37)
glucose homeostasis(35)
plasma glucose(35)
insulin secretion(33)
oxidative stress(31)
lipid metabolism(28)
metabolic syndrome(28)
physical activity(28)
electronic supplementary material(27)
significant increase(26)
weight gain(26)
cardiovascular risk(24)
bariatric surgery(22)
impaired glucose tolerance(22)
myocardial infarction(22)
significant reduction(22)
mouse model(21)
protein expression(21)
blood pressure(20)
significant difference(20)
systolic blood pressure(20)
beneficial effect(19)
fatty acid(19)
improved glucose tolerance(19)
risk factor(19)
waist circumference(19)
gene expression(18)
increased expression(18)
reactive oxygen species(17)
significant effect(17)
all-cause mortality(16)
family history(16)
fat mass(16)
mitochondrial function(16)
sensitivity analysis(16)
significant decrease(16)
transcription factor(16)
body composition(15)
clinical care(15)
energy expenditure(15)
fasting glucose(15)
hepatic steatosis(15)
intensive lifestyle intervention(15)
mitochondrial dysfunction(15)
glucose control(14)
informed consent(14)
low risk(14)
normal glucose tolerance(14)
statistical analysis(14)
clinical research(13)
diet-induced obesity(13)
lower risk(13)
metabolic control(13)
natural history(13)
reduced risk(13)
statistical significance(13)
data collection(12)
diabetic ketoacidosis(12)
energy homeostasis(12)
glucose uptake(12)
health care(12)
heart failure(12)
high glucose(12)
high prevalence(12)
positive association(12)
postprandial glucose(12)
protein kinase(12)
clinical trial(11)
coronary heart disease(11)
disease progression(11)
endoplasmic reticulum(11)
energy metabolism(11)
growing body(11)
hepatic glucose production(11)
improved insulin sensitivity(11)
lipid oxidation(11)
metabolic health(11)
precision medicine(11)
relative contribution(11)
significant improvement(11)
supporting information(11)
therapeutic potential(11)
article content(10)
cell death(10)
chronic kidney disease(10)
continuous glucose monitoring(10)
disease process(10)
endogenous glucose production(10)
energy intake(10)
fatty liver disease(10)
glucose cotransporter(10)
growth hormone(10)
increasing evidence(10)
intensive treatment(10)
marked increase(10)
metabolic regulation(10)
novo lipogenesis(10)
randomized controlled trial(10)
recent-onset type(10)
statistical power(10)
written informed consent(10)
basal insulin(9)
blood glucose concentration(9)
body fat(9)
causal relationship(9)
cumulative incidence(9)
data show(9)
direct comparison(9)
endothelial function(9)
fatty acid oxidation(9)
genetic risk(9)
glucose infusion rate(9)
gold standard(9)
independent risk factor(9)
lifestyle intervention(9)
lifestyle modification(9)
lipid profile(9)
mass spectrometry(9)
metabolic phenotype(9)
negative regulator(9)
oral glucose tolerance(9)
peroxisome proliferator(9)
position statement(9)
potential target(9)
protective effect(9)
receptor agonist(9)
renal disease(9)
significant association(9)
significant change(9)
blood flow(8)
cardiovascular mortality(8)
chronic inflammation(8)
clear evidence(8)
clinical data(8)
cognitive function(8)
data analysis(8)
disease duration(8)
energy balance(8)
excess risk(8)
fasting plasma glucose(8)
gastrointestinal tract(8)
glucagon-like peptide(8)
glucagon-like peptide-1(8)
healthy control(8)
high rate(8)
impaired fasting glucose(8)
incident type(8)
increased incidence(8)
individual patient(8)
insulin action(8)
islet function(8)
key component(8)
key regulator(8)
leading cause(8)
lipid accumulation(8)
liquid nitrogen(8)
mammalian target(8)
marked reduction(8)
metabolic disease(8)
nitric oxide(8)
normal glucose(8)
progressive loss(8)
risk stratification(8)
significant interaction(8)
statistically significant difference(8)
subcutaneous adipose tissue(8)
vascular endothelial growth factor(8)
adipocyte differentiation(7)
cell proliferation(7)
cell surface(7)
cell survival(7)
chronic disease(7)
convincing evidence(7)
differential expression(7)
effective treatment(7)
energy restriction(7)
ex vivo(7)
fat distribution(7)
fatty liver(7)
food intake(7)
genetic background(7)
genetic variant(7)
glucose disposal(7)
glucose production(7)
growing evidence(7)
growth factor(7)
hepatic gluconeogenesis(7)
high fat diet(7)
human type(7)
increased plasma(7)
increased susceptibility(7)
inflammatory response(7)
intensive glucose(7)
intensive therapy(7)
islet transplantation(7)
logistic regression(7)
long-term treatment(7)
mean ±(7)
median follow-up(7)
microvascular disease(7)
mitochondrial activity(7)
new-onset type(7)
next-generation sequencing(7)
nonalcoholic fatty liver disease(7)
novel approach(7)
novel therapeutic target(7)
oxygen consumption(7)
peripheral blood(7)
peripheral insulin sensitivity(7)
potential impact(7)
potential mechanism(7)
rapid increase(7)
rat model(7)
solid line(7)
subgroup analysis(7)
systemic inflammation(7)
therapeutic strategy(7)
weight change(7)
alcohol consumption(6)
blood glucose control(6)
cardiovascular death(6)
cardiovascular safety(6)
cell type(6)
childhood obesity(6)
continuous glucose(6)
correlation coefficient(6)
cytokine production(6)
data implicate(6)
diabetic nephropathy(6)
diabetic retinopathy(6)
diastolic blood pressure(6)
different cell(6)
direct effect(6)
disease onset(6)
endothelial dysfunction(6)
experimental evidence(6)
fetal growth(6)
first-line treatment(6)
flow cytometry(6)
genetic predisposition(6)
genetic risk score(6)
glucose variability(6)
glucose-lowering medication(6)
glycemic variability(6)
heart rate(6)
high expression(6)
human islet(6)
human skeletal muscle(6)
incidence rate(6)
increased adiposity(6)
increased type(6)
insulin-stimulated glucose uptake(6)
intensive glycemic control(6)
islet autoimmunity(6)
key player(6)
lactic acidosis(6)
life expectancy(6)
lipid synthesis(6)
long-standing type(6)
long-term follow-up(6)
long-term safety data(6)
longer duration(6)
longitudinal data(6)
low-grade inflammation(6)
maternal obesity(6)
mean value(6)
medical history(6)
metabolic flexibility(6)
metabolic homeostasis(6)
metabolic response(6)
mitochondrial biogenesis(6)
molecular mechanism(6)
neutral effect(6)
novel mechanism(6)
nuclear factor(6)
original research(6)
paraventricular nucleus(6)
patient care(6)
peripheral neuropathy(6)
placebo-controlled trial(6)
plasma membrane(6)
positive correlation(6)
positive effect(6)
potential bias(6)
potential therapeutic target(6)
predictive value(6)
proliferator-activated receptor(6)
randomised clinical trial(6)
regulatory approval(6)
related content(6)
relative importance(6)
renal failure(6)
renal function(6)
residual confounding(6)
serum cholesterol(6)
serum glucose(6)
severe hypoglycaemia(6)
similar pattern(6)
survival analysis(6)
therapeutic target(6)
visceral adipose tissue(6)
weight reduction(6)
western blotting(6)
2-h glucose(5)
acute effect(5)
adipose tissue inflammation(5)
advanced glycation end(5)
animal model(5)
autoimmune destruction(5)
beneficial metabolic(5)
blood pressure control(5)
blot analysis(5)
body weight loss(5)
bone marrow(5)
caloric restriction(5)
cardiometabolic risk(5)
cardiorespiratory fitness(5)
cardiovascular disease risk(5)
carotid intima-media thickness(5)
cell viability(5)
chronic exposure(5)
chronic treatment(5)
clinical benefit(5)
collaborative meta-analysis(5)
combination therapy(5)
compelling evidence(5)
compensatory increase(5)
comprehensive assessment(5)
concomitant increase(5)
consummatory lordosis quotient(5)
coronary artery disease(5)
dark cycle(5)
design 48h(5)
detrimental effect(5)
dietary intake(5)
double-blind trial(5)
fat accumulation(5)
fat storage(5)
fatty acid synthesis(5)
female sexual desire(5)
gastric inhibitory(5)
genetic variation(5)
glomerular filtration rate(5)
glucose monitoring(5)
glucose transporter(5)
glucose utilisation(5)
glycogen content(5)
gradual increase(5)
gut microbiome(5)
high proportion(5)
hospital admission(5)
human obesity(5)
hypoactive sexual desire disorder(5)
increased energy expenditure(5)
increased mortality(5)
increased physical activity(5)
increased serum(5)
increasing prevalence(5)
incremental area(5)
insulin receptor(5)
insulin release(5)
insulin tolerance(5)
insulinotropic polypeptide(5)
inverse relationship(5)
key mediator(5)
key question(5)
kidney disease(5)
latent autoimmune(5)
linear regression(5)
liquid chromatography(5)
liver steatosis(5)
long-term safety(5)
lower blood glucose(5)
lower rate(5)
magnetic resonance(5)
mechanistic insight(5)
mechanistic target(5)
medical care(5)
medical treatment(5)
mental health(5)
metabolic function(5)
metabolic risk(5)
metformin therapy(5)
mitochondrial content(5)
mitochondrial respiration(5)
mitogen-activated protein(5)
modest reduction(5)
negative impact(5)
nonalcoholic steatohepatitis(5)
novel strategy(5)
oxidative damage(5)
oxidative metabolism(5)
oxidative phosphorylation(5)
pancreatic progenitor(5)
paradigm shift(5)
pharmacological therapy(5)
potential risk(5)
promoter region(5)
prospective cohort(5)
prospective data(5)
protein response(5)
protein synthesis(5)
randomized placebo-controlled(5)
rate-limiting enzyme(5)
receptor substrate(5)
reduced expression(5)
regression analysis(5)
response relationship(5)
rheumatoid arthritis(5)
severe insulin resistance(5)
sex difference(5)
shorter duration(5)
significant impact(5)
study population(5)
subsequent development(5)
substantial reduction(5)
systematic evaluation(5)
testosterone propionate(5)
tight control(5)
underlying mechanism(5)
unique opportunity(5)
western blot(5)
western blot analysis(5)
white adipose tissue(5)
10-year follow-up(4)
abdominal obesity(4)
abstract form(4)
ad libitum(4)
ad libitum access(4)
add-on therapy(4)
adoptive transfer(4)
arcuate nucleus(4)
aromatic amino(4)
arterial stiffness(4)
aspartic acid(4)
baseline data(4)
big data(4)
brain structure(4)
capillary density(4)
cardiovascular health(4)
causal association(4)
cell biology(4)
cerebrovascular disease(4)
chronic autoimmune disease(4)
clinical diagnosis(4)
clinical experience(4)
clinical impact(4)
clinical information(4)
clinical management(4)
clinical relevance(4)
clinical risk(4)
clinical type(4)
clinical utility(4)
cognitive dysfunction(4)
cognitive impairment(4)
cognitive performance(4)
combined data(4)
compensatory mechanism(4)
comprehensive picture(4)
comprehensive update(4)
confocal microscopy(4)
confounding effect(4)
considerable variation(4)
continuous variable(4)
controlled trial(4)
conversion rate(4)
coronary artery(4)
data interpretation(4)
data reveal(4)
detailed description(4)
diabetes-related distress(4)
dietary intervention(4)
direct evidence(4)
disease status(4)
docosahexaenoic acid(4)
dose-response relationship(4)
ectopic expression(4)
ectopic fat accumulation(4)
emerging evidence(4)
endogenous ligand(4)
endoplasmic reticulum stress(4)
endothelial growth factor(4)
endothelial nitric oxide synthase(4)
essential component(4)
euglycaemic clamp(4)
evidence-based treatment(4)
发布时间
2016(1,139)
2015(868)
2019(755)
2018(667)
2014(571)
2017(478)
2002(1)
2009(1)
2010(1)
文档类型
PDF(56)
DOC(X)(0)
PPT(X)(0)
XLS(X)(0)
TEXT(0)
语言种类
英语(4474)
德语(1)
法语(2)
日语(0)
汉语(0)
其他(4)
发布时间跨度
从
到
